Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Alexander A. Fitzpatrick

At a glance: Alexander A. Fitzpatrick is General Counsel at ARS Pharmaceuticals (SPRY). Their latest SEC Form 4, filed Jun 12, 2026, reported a sale of $34K. On file: 0 purchase lines ($0) and 1 sale line ($34K).

Disclosed holdings: about $291K of SPRY stock: 90,910 shares reported on their latest Form 4 (filed Jun 12, 2026), valued at the Nov 19, 2026 close of $3.21. This counts only SPRY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

General Counsel at ARS Pharmaceuticals, Inc. (SPRY)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $34K

Alexander A. Fitzpatrick's InsiderPrint

4 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Alexander A. Fitzpatrick: 4 trades, 2020 to 20262020: 1 buy, 0 sales2021: 1 buy, 0 sales2022: 0 buys, 0 sales2023: 1 buy, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 0 buys, 1 sale

Reading this print: Mostly buys, trading about once a year, typically $34K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (3)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Mark T. BehrmanCEO, President · LXU · 99% match
  2. Anshooman AgaCFO · VNT · 98% match
  3. Kerrii B. AndersonDirector · LH · 97% match
  4. John R. SultDirector · VST · 96% match
  5. Stan W. ConnallyCOO · SO · 96% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Jun 12SEC SPRYARS Pharmaceuticals, Inc. Sell Plan 3,35590,910 held (−4%) $10.00 $34K -68.0%
  • Sell

    General Counsel Alexander A Fitzpatrick sold $34K of SPRY at $10.00 — pre-scheduled 10b5-1 plan sale.

Follow Alexander A. Fitzpatrick

Get one email when Alexander A. Fitzpatrick files a new purchase or sale. Free.

At most one email a day about Alexander A. Fitzpatrick, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.